Michael Dean Kinnick

Person

  • Indianapolis, IN, US

Patents Grantslast 30 patents

  • Information Patent Grant

    Multicyclic compounds for use as melanin concentrating hormone anta...

    • Patent number 7,229,987
    • Issue date Jun 12, 2007
    • Eli Lilly and Company
    • Jochen Ammenn
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Cyclopenta[b]indole derivatives as sPLA2 inhibitors

    • Patent number 7,160,909
    • Issue date Jan 9, 2007
    • Eli Lilly and Company
    • Michael Dean Kinnick
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    MCH receptor antagonists

    • Patent number 7,132,456
    • Issue date Nov 7, 2006
    • Eli Lilly and Company
    • James Ronald Gillig
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Cyclohept[b]indole derivatives

    • Patent number 7,109,231
    • Issue date Sep 19, 2006
    • Eli Lilly and Company
    • Michael Dean Kinnick
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    sPLA2 inhibitors

    • Patent number 6,992,100
    • Issue date Jan 31, 2006
    • Eli Lilly and Company
    • Douglas Wade Beight
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    sPLA2 inhibitors

    • Patent number 6,974,831
    • Issue date Dec 13, 2005
    • Eli Lilly and Company
    • Douglas Wade Beight
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    sPLA2 inhibitors

    • Patent number 6,930,123
    • Issue date Aug 16, 2005
    • Eli Lilly and Company
    • Douglas Wade Beight
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Spla2 inhibitors

    • Patent number 6,916,840
    • Issue date Jul 12, 2005
    • Eli Lilly and Company
    • Douglas Wade Beight
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    sPLA2 inhibitors

    • Patent number 6,872,743
    • Issue date Mar 29, 2005
    • Eli Lilly and Company
    • Douglas Wade Beight
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Substituted tricyclics

    • Patent number 6,713,645
    • Issue date Mar 30, 2004
    • Eli Lilly and Company
    • Nicholas James Bach
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    spla2 inhibitors

    • Patent number 6,713,505
    • Issue date Mar 30, 2004
    • Eli Lilly and Company
    • Michael Dean Kinnick
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Glycoprotein IIB/IIIA antagonists

    • Patent number 6,472,405
    • Issue date Oct 29, 2002
    • Eli Lilly and Company
    • Matthew J. Fisher
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Glycoprotein IIb/IIIa antagonists

    • Patent number 6,448,269
    • Issue date Sep 10, 2002
    • Eli Lilly and Company
    • Matthew J. Fisher
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Oxime amide indole type sPLA2 inhibitors

    • Patent number 6,391,908
    • Issue date May 21, 2002
    • Eli Lilly and Company
    • Nicholas James Bach
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Substituted tricyclics

    • Patent number 6,177,440
    • Issue date Jan 23, 2001
    • Eli Lilly and Company
    • Nicholas James Bach
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Glycoprotein IIb/IIIa antagonists

    • Patent number 6,137,002
    • Issue date Oct 24, 2000
    • Eli Lilly and Company
    • Matthew J. Fisher
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Glycoprotein IIB IIIA antagonists

    • Patent number 6,020,362
    • Issue date Feb 1, 2000
    • Eli Lilly and Company
    • Matthew J. Fisher
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Cell adhesion inhibitors

    • Patent number 6,013,674
    • Issue date Jan 11, 2000
    • Eli Lilly and Company
    • John Michael Morin
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Glycoprotein IIb/IIIa antagonists

    • Patent number 5,731,324
    • Issue date Mar 24, 1998
    • Eli Lilly and Company
    • Matthew J. Fisher
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Glycoprotein IIb/IIIa antagonists

    • Patent number 5,618,843
    • Issue date Apr 8, 1997
    • Eli Lilly and Company
    • Matthew J. Fisher
    • C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents